• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

9,3"-二乙酰麦迪霉素干糖浆在儿科应用的经验

[Experience with the use of 9,3"-diacetylmidecamycin dry syrup in pediatrics].

作者信息

Kobayashi Y, Haruta T, Kuroki S, Ohkura K

出版信息

Jpn J Antibiot. 1982 May;35(5):1207-11.

PMID:6982351
Abstract

Some studies were carried out on the use of 9,3"-diacetylmidecamycin (MOM) dry syrup, a new macrolide antibiotic preparation, in the treatment of children. The results are summarized below. 1) A single oral dose of 10 mg/kg of the MOM dry syrup was administered to 1 child at 2 hours after a meal. The peak concentration of the antibiotic in the blood was 0.88 micrograms/ml and occurred at 1 hour after administration. At 2 hours the concentration had fallen to 0.59 microgram/ml, and after 4 hours the blood level was already below the minimum detectable concentration (0.5 microgram/ml). During the first 6 hours after the administration, 6.7% of the MOM was recovered in the urine. 2) The MOM dry syrup was orally administered to 4 pneumonia patients (including 2 cases of mycoplasmal pneumonia) for 7 days at a daily dosage of 15.2--20.5 mg/kg (divided into 3 equal doses). The therapeutic results were excellent in 2 cases, good in 2 cases and poor in none. 3) No side effects such as exanthema were observed to occur. In 1 case only, there was a mild and temporary elevation in the laboratory test values for total bilirubin, GOT and GTP. 4) All 4 of the pneumonia patients found the MOM dry syrup to be easy to ingest. The taste and odor of this antibiotic preparation were judged to be sufficiently palatable to permit convenient use in the treatment of children.

摘要

对一种新型大环内酯类抗生素制剂9,3"-二乙酰麦迪霉素(MOM)干糖浆用于儿童治疗进行了一些研究。结果总结如下。1)在饭后2小时给1名儿童口服单剂量10mg/kg的MOM干糖浆。抗生素在血液中的峰值浓度为0.88微克/毫升,于给药后1小时出现。2小时时浓度降至0.59微克/毫升,4小时后血药水平已低于最低检测浓度(0.5微克/毫升)。给药后的前6小时内,6.7%的MOM在尿液中回收。2)对4例肺炎患者(包括2例支原体肺炎)口服MOM干糖浆,每日剂量为15.2 - 20.5mg/kg(分3等份),持续7天。治疗结果2例为优,2例为良,无差的病例。3)未观察到诸如皮疹等副作用发生。仅1例患者的总胆红素、谷草转氨酶和谷丙转氨酶实验室检测值有轻度且短暂的升高。4)4例肺炎患者均认为MOM干糖浆易于服用。这种抗生素制剂的味道和气味被判定为足够可口,便于用于儿童治疗。

相似文献

1
[Experience with the use of 9,3"-diacetylmidecamycin dry syrup in pediatrics].9,3"-二乙酰麦迪霉素干糖浆在儿科应用的经验
Jpn J Antibiot. 1982 May;35(5):1207-11.
2
[Clinical study on 9,3"-diacetylmidecamycin in the field of pediatrics (author's transl)].9,3"-二乙酰麦迪霉素在儿科领域的临床研究(作者译)
Jpn J Antibiot. 1982 Apr;35(4):909-18.
3
[Studies on 9,3"-diacetylmidecamycin dry syrup in pediatric acute respiratory tract infections (author's transl)].9,3"-二乙酰麦迪霉素干糖浆治疗小儿急性呼吸道感染的研究(作者译)
Jpn J Antibiot. 1982 Jan;35(1):240-50.
4
[Clinical results of 9, 3"-diacetylmidecamycin dry syrup in the pediatric field (author's transl)].9,3”-二乙酰麦迪霉素干糖浆在儿科领域的临床结果(作者译)
Jpn J Antibiot. 1982 Mar;35(3):766-9.
5
[Laboratory and clinical studies of rokitamycin dry syrup in the field of pediatrics].
Jpn J Antibiot. 1988 Jul;41(7):875-84.
6
[Clinical studies of 9,3"-diacetylmidecamycin in pediatric field (author's transl)].
Jpn J Antibiot. 1982 Feb;35(2):421-8.
7
[Laboratory and clinical studies of 9,3"-diacetylmidecamycin in the pediatric field].9,3"-二乙酰麦迪霉素在儿科领域的实验室及临床研究
Jpn J Antibiot. 1982 May;35(5):1199-206.
8
[Clinical studies of rokitamycin dry syrup in the field of pediatrics].罗他霉素干糖浆在儿科领域的临床研究
Jpn J Antibiot. 1988 Jul;41(7):914-9.
9
[Clinical studies on 9, 3"-diacetylmidecamycin in respiratory tract infections in the field of pediatrics (author's transl)].9,3”-二乙酰麦迪霉素治疗小儿呼吸道感染的临床研究(作者译)
Jpn J Antibiot. 1982 Mar;35(3):739-53.
10
[Microbiological, pharmacokinetic and clinical studies of rokitamycin dry syrup in the pediatric field].
Jpn J Antibiot. 1988 Jul;41(7):920-59.